Duke GU Tumor Board   

If ADT +/- ARPI + RT, what duration of systemic therapy do you recommend?

Would you use it for initial staging or at time of biochemical recurrence?

Does patient age effect your approach? Would you consider RPLND for any patients in light of the phase II SEMS trial presented at the 2021 ASCO GU Ca...